Left Menu
Development News Edition

Sun Pharma gets DCGI nod to conduct clinical trials of potential COVID-19 drug

PTI | New Delhi | Updated: 29-05-2020 16:55 IST | Created: 29-05-2020 16:55 IST
Sun Pharma gets DCGI nod to conduct clinical trials of potential COVID-19 drug

Drug major Sun Pharma on Friday said it has received approval from the Drugs Controller General of India (DCGI) to initiate a clinical trial of Nafamostat Mesilate on COVID-19 patients Nafamostat is approved in Japan for improvement of acute symptoms of pancreatitis and treatment of disseminated intravascular coagulation (DIC). “Sun Pharma is constantly evaluating potential targets that can be explored for treating COVID-19 patients. Nafamostat has shown promising data  against SARS-CoV-2 virus in in-vitro studies conducted by three independent groups of scientists in Europe, Japan and South Korea," Sun Pharmaceutical Industries MD  Dilip Shanghvi said in a statement.

The Mumbai-based firm believes the drug holds promise in the treatment of COVID-19 patients, he added. Considering the pandemic situation and urgent need for newer treatment options, the company said it plans to initiate the clinical trials at the earliest.  The company has initiated manufacturing of both, the API and  the finished product of Nafamostat in India, using technology from its subsidiary, Pola Pharma Japan, it added.

A group of scientists from the University of Tokyo, Japan and Leibniz Institute for Primate Research, Germany, have recently demonstrated that Nafamostat, at very low concentrations, suppresses a protein (TMPRSS2) which the COVID-19 virus uses to enter human lung cells, the drug firm noted.  Globally, there are three clinical trials currently underway to test Nafamostat in COVID-19 patients.  These trials are being led by the University of Tokyo Hospital, Japan; Gyeongsang National University Hospital (South Korea); and a collaborative trial by University Hospital, Padova, Italy, University of Zurich, Switzerland and Yokohoma City University, Japan..



COVID-19 seems cooking biggest ever global scam

The increasing number of corruption cases on COVID-19 funds from throughout the world and involvement of high profile persons indicate that the countries cant ignore corruption in their pandemic response programs. This has generated the nee...

Health Management Information Systems lack holistic, integrated, and pandemic resilient character

Being a part of the United Nations system, the World Health Organization WHO deserves its share of rebuke for its alleged failure issue COVID-19 health emergency alerts on appropriate time. However, the pandemic has also exposed loopholes i...

Pride in the time of coronavirus: a welcome move online?

This year is different in many ways not least as celebrations are also taking place against the dramatic backdrop of a global health crisis and a resurgence in grassroots activism following the death of George Floyd in Minneapolis. ...

COVID-19: Weighing up the benefits and limitations of edtech platforms

Edtech companies shouldnt focus on merely pushing contents, but to provide an interactive, effective teaching and learning environment. ...


Latest News

Would have changed my game to be a T20 player: Ganguly backs format

BCCI president Sourav Ganguly on Sunday lent his support for T20 cricket, saying he would have reinvented his game to meet the demands of the shortest format if he was playing in this era. T20 is very important. I would have changed my game...

'Lootera' team celebrates film’s seventh anniversary

Filmmaker Vikramaditya Motwane and actors Ranveer Singh and Sonakshi Sinha on Sunday celebrated seven years of their film Lootera. Set in the 1950s, the romantic-drama chronicled the story of a young conman Ranveer posing as an archaeologis...

Simpler way to generate sensory hearing cells: Study

Researchers have now found a simpler way of generating the sensory cells of the inner ear. The team uses a direct reprogramming approach to produce sensory cells known as hair cells, due to their hair-like protrusions that sense sound waves...

Shift Millennium Bus Depot from Yamuna flood plains: NGT appointed panel

A committee appointed by the National Green Tribunal NGT to monitor cleaning of the Yamuna has recommended that the Delhi Transport Corporation DTC shift the Millennium Bus Depot as it lies on the rivers flood plain and said it is environme...

Give Feedback